Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trypanosomal kinetoplast DNA (kDNA) is a unique and complex mitochondrial genome structure found in kinetoplastid protozoa, such as Trypanosoma and Leishmania species (Jensen & Englund, 1998, Cell). It consists of a massive, catenated network of thousands of circular DNA molecules, categorized into maxicircles and minicircles (Shapiro & Englund, 1995, Annu Rev Microbiol). Maxicircles encode essential components of the mitochondrial respiratory chain, while minicircles encode guide RNAs necessary for the extensive RNA editing of maxicircle transcripts (Stuart et al., 2005, Science). Because this structure is absent in mammalian cells, it serves as a highly specific therapeutic target for antiparasitic agents (D'Ambrosio et al., 2016, Molecules). Drugs like pentamidine and diminazene target kDNA by binding to its minor groove, particularly in AT-rich regions, which interferes with DNA replication and the activity of mitochondrial topoisomerases (Wilson et al., 2008, Curr Med Chem). This disruption leads to the loss of the kDNA network, a condition known as dyskinetoplasty, which ultimately results in parasite death due to the failure of mitochondrial energy metabolism (Schnaufer et al., 2002, Science).
Drugs typically bind to the minor groove of AT-rich regions or intercalate into the DNA, leading to the inhibition of mitochondrial topoisomerases, disruption of the catenated network structure, and eventual loss of mitochondrial function (Wilson et al., 2008, Curr Med Chem).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trypanosomal kinetoplast DNA (kDNA).